Wei Dai

机构：Nanjing University of Finance and Economics, University of Electronic Science and Technology of China, Army Medical University, Guangxi Medical University, Shanghai University of Sport, Sichuan Cancer Hospital, First Affiliated Hospital of GuangXi Medical University, Southwest Hospital, Sichuan Institute of Building Research, Jiangsu Province Hospital, North Dakota State University, Lanzhou University · ORCID：0000-0003-1650-1590

发表论文 278 篇 · 总被引 3128 次 · h-index 30

代表论文

• SOX4-ZIP14-zinc metabolism mediates oncogenesis and suppresses T cell immunity in nasopharyngeal carcinoma (2025 · Cell Reports Medicine · 被引 5)
• Cancer-associated fibroblast-induced lncRNA WARS2-IT1 confers radioresistance of colorectal cancer via enhancing HIF-1α stability (2025 · Cell Death and Disease · 被引 4)
• Unlocking Neuroprotection: Simultaneous Suppression of Mitochondrial Energetic Collapse and Oxidative-Inflammatory Vortex for Ischemia-Reperfusion Brain Injury (2025 · ACS Nano · 被引 4)
• A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028 (2025 · Frontiers in Immunology · 被引 4)
• A Novel Score for Predicting Long‐Term Outcomes in Recanalisation‐Treated Patients With Budd‐Chiari Syndrome: A Multicentre Study (2025 · Liver International · 被引 3)
• Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study (2026 · Annals of Surgical Oncology · 被引 1)